Type-1 plasminogen-activator inhibitor. Conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility

European Journal of Biochemistry

Volumn 248, Issue 3, 1997, Pages 775-785

  Egelund, Rikke ^a   Schousboe, Susanne L ^a   Sottrup Jensen, Lars ^a   Rodenburg, Kees W ^a   Andreasen, Peter A ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Limited proteolysis; Plasminogen activator; Serine proteinase; Serpin; Type 1 plasminogen activator inhibitor

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CONFORMATIONAL TRANSITION; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN STRUCTURE;

EID: 0030841490     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.t01-1-00775.x     Document Type: Article

References (48)

1. Aertgeerts, K., De Bondt, H. L., De Ranter, C. J. & Declerck, P. J. (1994) A model of the reactive form of plasminogen-activator inhibitor-1, J. Struct. Biol. 113, 239-245.
2. Aertgeerts, K., De Bondt, H. L., De Ranter, C. J. & Declerck, P. J. (1995) Mechanisms contributing to the conformational and functional flexibility of plasminogen-activator inhibitor-1. Nat. Struct. Biol. 2, 891-897.
3. Andreasen, P. A., Nielsen, L. S., Kristensen, P., Grøndahl-Hansen, J., Skriver, L. & Danø, K. (1986a) Plasminogen-activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme. J. Biol. Chem. 261, 7644-7651.
4. Andreasen, P. A., Riccio, A., Welinder, K. G., Douglas, R., Sartorio, R., Nielsen, L. S., Oppenheimer, C., Blasi, F. & Danø, K. (1986b) Plasminogen-activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing. FEBS Lett. 209, 213-218.
5. Andreasen, P. A., Georg, B., Lund. L. R., Riccio, A. & Stacey, S. N. (1990) Plasminogen-activator inhibitors: hormonally regulated serpins. Mol. Cell. Endocrinol. 68, 1-19.
6. Andreasen, P. A., Kjøller, L., Christensen, L. & Duffy, M. J. (1997) The urokinase-type plasminogen activator system in cancer metastasis. A review, Int. J. Cancer 72, 1-22.
7. Bode, W. & Huber, R. (1992) Natural protein proteinase inhibitors and their interaction with proteinases, Eur. J. Biochem. 204, 433-451.
8. Carrell, R. W., Stein, P. E., Fermi, G. & Wardell, M. R. (1994) Biological implications of a 3 Å structure of dimeric antithrombin, Structure (Lond.) 2, 257-270.
9. Carrell, R. W. & Stein, P. E. (1996) The biostructural pathology of the serpins: critical function of sheet opening mechanism, Biol. Chem. Hoppe-Seyler 377, 1-17.
10. 1-macroglobulin receptor in human breast carcinomas, Int. J. Cancer 66, 441-452.
11. Creighton, T. E. (1993) Proteins in solution and in membranes, in Proteins: structures and molecular properties, 2nd edn, pp. 261-325. W. H. Freeman and Company, New York.
12. Deng, G., Royle, G., Seiffert, D. & Loskutoff, D. (1995) The PAI-1/vitronectin interaction: two cats in a bag? Thromb. Haemostasis 74, 66-70.
13. 1-antitrypsin. Nat. Struct. Biol. 3, 676-681.
14. Gils, A., Knockaert, I. & Declerck, P. J. (1996) Substrate behavior of plasminogen-activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop, Biochemistry 35, 7474-7481.
15. Hekman, C. M. & Loskutoff, D. J. (1985) Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturation, J. Biol. Chem. 260, 11 581-11 587.
16. Hubbard, S. J., Eisenmenger, F. & Thornton, J. M. (1994) Modeling studies of the change in conformation required for cleavage of limited proteolytic sites, Protein Sci. 3, 757-768.
17. Huber, R. & Carrell, R. W. (1989) Implications of the three-dimensional structure of σ1-antitrypsin for structure and functions of serpins, Biochemistry 28, 8951-8966.
18. Kjøller, L., Martensen, P. M., Sottrup-Jensen, L., Justesen, J., Rodenburg, K. W. & Andreasen, P. A. (1996) Conformational changes of the reactive-center loop and β-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor-1, Eur. J. Biochem. 241, 38-46.
19. Kjøller, L., Kanse, S. M., Kirkegaard, T., Rodenburg, K. W., Rønne, E., Goodman, S. L., Preissner, K. T., Ossowski, L. & Andreasen, P. A. (1997) Plasminogen-activator inhibitor-1 represses integrin-and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation, Exp. Cell Res. 232, 420-429.
20. Kraulis, P. J. (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.
21. Lawrence, D. A., Olson, S. T., Palaniappan, S. & Ginsburg, D. (1994) Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition, J. Biol. Chem. 269, 27 657-27 662.
22. Lawrence, D. A., Ginsburg, D., Day, D. E., Berkenpas, M. B., Verhamme, I. M., Kvassman, J. O. & Shore, J. D. (1995) Serpin-protease complexes are trapped as stable acyl-enzyme intermediates. J. Biol. Chem. 270, 25 309-25 312.
23. Lukacs, C. M., Zhong, J. Q., Plotnick, M. L. Harvey, R., Cooperman, B. S. & Christianson, D. W. (1996) Arginine substitutions in the hinge region of antichymotrypsin affect serpin β-sheet rearrangement. Nat. Struct. Biol. 3, 888-893.
24. 1-proteinase inhibitor probed by limited proteolysis, Biochemistry 31, 2720-2728.
25. Mottonen, J., Strand, A., Symersky, J., Sweet, R. M., Danley, D. B., Geoghegan, K. F., Gerard, R. D. & Goldsmith, E. J. (1992) Structural basis of latency in plasminogen-activator inhibitor-1, Nature 355, 270-273.
26. Munch, M., Heegaard, C. W., Jensen, P. H. & Andreasen, P. A. (1991) Type-1 inhibitor of plasminogen activator: Distinction between latent, active and reactive-center-cleaved forms with thermal stability and monoclonal antibodies, FEBS Lett. 295, 102-106.
27. Munch, M., Heegaard, C. W. & Andreasen, P. A. (1993) Interconversions between active, inert and stibstrate forms of denatured/refolded type-1 plasminogen-activator inhibitor, Biochim. Biophys. Acta 1202, 29-37.
28. 1 54 000-molecular-weight plasminogen-activator inhibitor from fibrosarcoma cells-inhibitor neutralisation and one-step affinity purification, Thromb. Haemostasis 55, 206-212.
29. Padmanabhan, J. & Sane, D. C. (1995) Localisation of a vitronectin binding region of plasminogen-activator inhibitor-1, Thromb. Haemostasis 73, 829-834.
30. Potempa, J., Korzus, B. & Travis, J. (1994) The serpin superfamily of proteinase inhibitors: structure, function, and regulation, J. Biol. Chem. 269, 15 957-15 960.
31. Preissner, K. T. & Jenne, D. (1991) Structure of vitronectin and its biological role in haemostasis. Thromb. Haemostas. 66, 123-132.
32. Price, N. C. & Johnson, C. M. (1989) Proteinases as probes of conformation of soluble proteins, in Proteolytic enzymes: a practical approach (Beynon, R. J. & Bond, J. S., eds) pp. 163-180, IRL Press, Oxford.
33. Schreuder, H. A., de Boer, B., Dijkema, R., Mulders, J., Theunissen, H. J., Grootenhuis, P. D. & Hol, W. G. (1944) The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions, Nat. Struct. Biol. 1, 48-54.
34. Schulze, A. J., Huber, R., Bode, W. & Engh, R. A. (1994) Structural aspects of serpin inhibition. FEBS Lett. 344, 117-124.
35. Schulze, A. J., Quarzago, D. & Andreasen, P. A. (1996) A spectroscopic study of the structures of latent, active and reactive center-cleaved type-1 plasminogen-activator inhibitor, Eur. J. Biochem. 240, 550-555.
36. Seetharam, R., Dwivedi, A. M., Duke, J. L., Hayman, A. C., Walton, H. L., Huckins, N. R., Kamarkar, S. M., Corman, J. I., Woodeshick, R. W., Wilk, R. R. & Reilly, T. M. (1992) Purification and characterisation of active and latent forms of recombinant plasminogen-activator inhibitor 1 produced in Escherichia coli, Biochemistry 31, 9877-9882.
37. 1-antitrypsin reveals the conformation of its inhibitory reactive loop. FEBS Lett. 377, 150-154.
38. Sottrup-Jensen, L. (1995) A low-pH reverse-phase high-performance liquid chromatography system for analysis of the phenylthiohydantoins of S-carboxymethylcysteine and S-carboxyamidomethylcycsteine. Anal. Biochem. 225, 187-188.
39. Stein, P. E., Leslie, A. G. W., Finch, J. T., Turnell, W. G., McLaughlin, P. J. & Carrell, R. W. (1990) Crystal structure of ovalbumin as a model for the reactive-center of serpins, Nature 347, 99-102.
40. Stein, P. E. & Chothia, C. (1991) Serpin tertiary structure transformation. J. Mol. Biol. 221, 615-621.
41. Stein, P. E. & Carrell, R. W. (1995) What do dysfunctional serpins tell us about molecular mobility and disease? Nat. Struct. Biol. 2, 96-113.
42. Stratikos, E. & Gettins, P. G. W. (1997) Major proteinase movement upon stable serpin-proteinase complex formation. Proc. Natl Acad. Sci. USA 94, 453-458.
43. van Meijer, M., Gebbink, R. K., Preissner, K. T. & Pannekoek, H. (1994) Determination of the vitronectin binding site on plasminogen-activator inhibitor 1 (PAI-1). FEBS Lett. 352, 342-346.
44. Wang, Z., Mottonen, J. & Goldsmith, E. J. (1996) Kinetically controlled folding of the serpin plasminogen-activator inhibitor 1, Biochemistry 35, 16 443-16 448.
45. Wei, A., Rubin, H., Cooperman, B. S. & Christianson, D. W. (1994) Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop. Nat. Struct. Biol. 1, 251-258.
46. Wilczynska, M., Fa, M., Ohlsson, P. I. & Ny, T. (1995) The inhibition mechanism of serpins. Evidence that the mobile reactive center loop is cleaved in the native protease-inhibitor complex, J. Biol. Chem. 270, 29 652-29 655.
47. Wilczynska, M., Fa, M., Karolin, J., Ohlsson, P. I., Johansson, L. B. A. & Ny, T. (1997) Structural insight into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nat. Struct. Biol. 4, 354-357.
48. Wright, H. T. & Scarsdale, J. N. (1995) Structural basis for serpin inhibitor activity, Proteins: Struct. Funct. Genet. 22, 210-225.